Compare ADMA Biologics Inc (ADMA) vs Western Digital Corp (WDC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Western Digital Corp — how do they compare? ADMA Biologics Inc trades at $9.27 (market cap $2.13B), while Western Digital Corp trades at $533.77 (market cap $183.41B). The key difference: Western Digital Corp is far larger — about 86.1× ADMA Biologics Inc's market cap, and Western Digital Corp pays a 0.11% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | WDC | |
|---|---|---|
Market Cap | $2.13B | $183.41B |
Sector | Health | Technology |
52-Week High | $20.38 | $746.23 |
52-Week Low | $7.60 | $64.02 |
Enterprise Value | $2.20B | $181.75B |
Dividend Yield | — | 0.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
Western Digital (WDC) trades at $532.1, down 1.28% amid a sector-wide memory stock sell-off. The stock shows strong fundamentals with three consecutive quarterly earnings beats and a net income margin of 55.07% in 2025. Analyst consensus is strongly bullish with a $607.46 price target, though technical indicators signal near-term bearish pressure with support at $523.
Outlook remains positive driven by AI and data center demand, but volatility from memory pricing cycles and competitive pressures pose risks. Upside depends on continued execution and sector momentum, with the current dip potentially offering entry for growth-oriented investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
